Related Experiment Video
Updated: Mar 12, 2026
06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.4K
Time to consider sharing data extracted from trials included in systematic reviews
Luke Wolfenden1,2, Jeremy Grimshaw3, Christopher M Williams4,5
1Hunter New England Population Health, Locked Bag 10 Longworth Ave, Wallsend, New South Wales, 2289, Australia. Luke.Wolfenden@hnehealth.nsw.gov.au.
Systematic Reviews
|November 5, 2016
Summary
Sharing data from systematic reviews offers significant benefits, including reduced duplication and improved efficiency for future research. Embracing open access maximizes the value of research investments in systematic reviews.
Area of Science:
- Health Sciences
- Medical Research
- Evidence Synthesis
Background:
- The discussion on clinical trial data sharing has evolved from 'if' to 'how'.
- Sharing data from systematic reviews, however, remains underexplored.
- This commentary highlights the advantages of coordinated systematic review data sharing.
Discussion:
- Systematic review data sharing can prevent redundant research efforts.
- It reduces the burden on trialists responding to repeated data requests.
- Enhanced data accessibility improves the quality and efficiency of future systematic reviews.
Key Insights:
- Shared systematic review data supports methodological research for clinical trials and reviews.
- It enables secondary analyses for novel research questions.
- Addressing concerns about data use, costs, and author credit is crucial for open access.
Outlook:
- Developing infrastructure for systematic review data access is progressing.
- Open access to systematic review data maximizes research investment returns.
- Wider adoption of data sharing systems will benefit the scientific community.
Related Concept Videos
01:16Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
01:11Clinical Trials: Overview
5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
01:12Hazard Ratio
681
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
681
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
519
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
519
01:13Data Collection by Experiments
27.9K
Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public...
An example of the experimental method is a public...
27.9K
01:13Bioequivalence studies: Biowaivers
366
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
366